SSSCA1 Antibody (N-term ) Blocking peptide
€363.00
In stock
SKU
AC-BP13654a
Background:
This antigen is recognized by a subset of anti-centromereantibodies from patients with scleroderma and/or Sjogren'ssyndrome. Subcellular localization has not yet been established.
Other Names:
Sjoegren syndrome/scleroderma autoantigen 1, Autoantigen p27, SSSCA1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13654a was selected from the N-term region of SSSCA1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ZNRD2 (HGNC:11328)
Gene ID: 10534
Primary Accession: O60232
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This antigen is recognized by a subset of anti-centromereantibodies from patients with scleroderma and/or Sjogren'ssyndrome. Subcellular localization has not yet been established.
Other Names:
Sjoegren syndrome/scleroderma autoantigen 1, Autoantigen p27, SSSCA1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13654a was selected from the N-term region of SSSCA1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ZNRD2 (HGNC:11328)
Gene ID: 10534
Primary Accession: O60232
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review